-
It's
#DIA2019 poster time! Visit Matt Eberle's poster on "Identifying Gaps in Competitive Intelligence and Business Development Strategy: New Opportunities in the PD-1/PD-L1 Development Landscape.” pic.twitter.com/xrHraUDyDk
-
Can't think of a more important topic or better people to be discussing: “Who Owns My Health Data: Patients, Data, and the Future of R&D" at
#DIA2019@hmkyale@DCPatient@CraigLipset@HealthPrivacy@ACROhealthpic.twitter.com/aIcwOaoE45
-
The exhibit hall is opening now! Enjoy your coffee, refreshments, & the exhibit hall before stopping by ERT’s booth.
#dia2019 pic.twitter.com/TzQZxSw3SN#dia2019 Visit ERT at Booth 1231 -
Looking for a great session this morning
#DIA2019? Come on over to 14b to chat about data collection in preapproval access. -
So honored to participate in
#DIA2019 with this amazing panel@tsalliance@GlobalGenes discussing “How to Solve the Problem of Access for Rare Diseases.”pic.twitter.com/6bXhxqazBt
-
Ready for the
@IMI_PREFER chat show to begin!!#DIA2019 pic.twitter.com/pWxpxdqdhI
-
Patient advocates making connections
@DrugInfoAssn#DIA2019 @WCGClinicalpic.twitter.com/LniAW4l5Li
-
Thank you to everyone who stopped by our breakfast event this morning! We’ve had many meaningful conversations, but there are still more to be had during day two of
#DIA2019. pic.twitter.com/KdHaAsTscj
-
Proud to be a part of this year’s program committee for
#DIA2019#DIAPMCommunitypic.twitter.com/zMFXvMATtN
-
#MarkLogic Pharma Research Hub accelerates innovation#DIA2019 @imrantechpic.twitter.com/goIJqWYYLY
-
Thank you to
@LifeSciLeader1 for recognizing Rho at the CRO Awards#DIA2019 pic.twitter.com/vEsi8g9O0E
-
Our poster at
#DIA2019! Thanks,@IntervalGoat, for presenting it!
pic.twitter.com/SXnLnn6SJM
Prikaži ovu nit -
Excited to be speaking on 3 panels at DIA , on patient experience data, streamlined approach for trials in severe, life threatening diseases and patient experiences in rare disease trials
#DIA2019@Amyloidosis_ARCpic.twitter.com/JNIbagfpLy – mjesto: San Diego Convention Center
-
“Nobody is paying attention to us — we have to get a registry. And our registry really transformed us and got us to where we are today...” -Pam Mace, ED, Fibromuscular Dysplasia Society of America, speaking at
#DIA2019 pic.twitter.com/AFeJRaDbVK
-
What does it mean to be a “healthcare-enabling research organization” (HERO)? Elligo’s CEO,
@JohnGPotthoff sat down with@Clin_Trials to explain yesterday at#DIA2019. Get in touch if you want to learn more. pic.twitter.com/5Igoml1fKx -
Come and join Sarah
@ICONplc and I@SproutBehaviour at 3.15pm today for our worksop "Assessing Medical Adherence in a Clinical Trial Setting: Challenges and Solutions" at#DIA2019 in San Diego, 3:15pm - 4:00pm in the E and E Area Exh Hall pic.twitter.com/47P0l8MO69
-
Structured content authoring demonstrated by
@AMPLEXOR at@DrugInfoAssn#dia2019 pic.twitter.com/XFCDPyBmXz – mjesto: San Diego Convention Center: Hall E
-
Had an incredible first day at
#DIA2019 with@IBMWatsonHealth! Clinical development is in the middle of a pivotal transformation, so it’s truly a privilege to join some of the brightest minds in the industry herepic.twitter.com/PDspZCrcOZ
-
Come to room 10 at
#dia2019 and hear some eCOA/ePRO experts (and me) enlighten and entertain the audience! pic.twitter.com/STkEFCuCdC
-
Lots going on at the hyperCORE booth (#2722) at the DIA Conference in San Diego!
#hypercoreintl#researchaccelerated#DIA2019 pic.twitter.com/e22M2uCPi2
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.